104 related articles for article (PubMed ID: 25152367)
1. NF-κB (p65) negatively regulates myocardin-induced cardiomyocyte hypertrophy through multiple mechanisms.
Liao XH; Wang N; Zhao DW; Zheng DL; Zheng L; Xing WJ; Zhou H; Cao DS; Zhang TC
Cell Signal; 2014 Dec; 26(12):2738-48. PubMed ID: 25152367
[TBL] [Abstract][Full Text] [Related]
2. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin.
Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC
Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation.
Li W; Wang N; Li M; Gong H; Liao X; Yang X; Zhang T
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):687-95. PubMed ID: 26206583
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of cytomegalovirus IE2 and myocardin on cardiomyocyte hypertrophy.
Zhou J; Liao XH; Wu C; Li J; Xiao R; Cheng C; Wang N; Cao D; Zhang TC
FEBS Lett; 2011 Apr; 585(7):1082-8. PubMed ID: 21385583
[TBL] [Abstract][Full Text] [Related]
5. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts.
Wang J; Li A; Wang Z; Feng X; Olson EN; Schwartz RJ
Mol Cell Biol; 2007 Jan; 27(2):622-32. PubMed ID: 17101795
[TBL] [Abstract][Full Text] [Related]
6. NFATc4 and myocardin synergistically up-regulate the expression of LTCC α1C in ET-1-induced cardiomyocyte hypertrophy.
Li M; He HP; Gong HQ; Zhang J; Ma WJ; Zhou H; Cao DS; Wang N; Zhang TC
Life Sci; 2016 Jun; 155():11-20. PubMed ID: 27155398
[TBL] [Abstract][Full Text] [Related]
7. Use of atorvastatin to inhibit hypoxia-induced myocardin expression.
Chiu CZ; Wang BW; Shyu KG
Eur J Clin Invest; 2012 May; 42(5):564-71. PubMed ID: 22129233
[TBL] [Abstract][Full Text] [Related]
8. miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300.
Duan Y; Zhou B; Su H; Liu Y; Du C
Exp Cell Res; 2013 Feb; 319(3):173-84. PubMed ID: 23211718
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation.
Badorff C; Seeger FH; Zeiher AM; Dimmeler S
Circ Res; 2005 Sep; 97(7):645-54. PubMed ID: 16141410
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of myocardial hypertrophy regulated by the interaction between mhrt and myocardin.
Luo Y; Xu Y; Liang C; Xing W; Zhang T
Cell Signal; 2018 Mar; 43():11-20. PubMed ID: 29199045
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis.
Xu Y; Luo Y; Liang C; Zhang T
J Mol Cell Cardiol; 2020 Feb; 139():47-61. PubMed ID: 31982428
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
Jiang DS; Luo YX; Zhang R; Zhang XD; Chen HZ; Zhang Y; Chen K; Zhang SM; Fan GC; Liu PP; Liu DP; Li H
Hypertension; 2014 Jan; 63(1):119-27. PubMed ID: 24144649
[TBL] [Abstract][Full Text] [Related]
13. Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression.
Tang RH; Zheng XL; Callis TE; Stansfield WE; He J; Baldwin AS; Wang DZ; Selzman CH
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3362-7. PubMed ID: 18296632
[TBL] [Abstract][Full Text] [Related]
14. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
Wang K; Long B; Zhou J; Li PF
J Biol Chem; 2010 Apr; 285(16):11903-12. PubMed ID: 20177053
[TBL] [Abstract][Full Text] [Related]
15. Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.
Madonna R; Geng YJ; Bolli R; Rokosh G; Ferdinandy P; Patterson C; De Caterina R
J Biol Chem; 2014 Jul; 289(28):19585-98. PubMed ID: 24855642
[TBL] [Abstract][Full Text] [Related]
16. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
Yu L; She T; Li M; Shi C; Han L; Cheng M
Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
[TBL] [Abstract][Full Text] [Related]
17. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
McKay LI; Cidlowski JA
Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
[TBL] [Abstract][Full Text] [Related]
18. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
[TBL] [Abstract][Full Text] [Related]
19. MiR-466h-5p induces expression of myocardin with complementary promoter sequences.
Luo Y; Liang C; Xu Y; Zhang T
Biochem Biophys Res Commun; 2019 Jun; 514(1):187-193. PubMed ID: 31029421
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
